Christopher E M Griffiths, Melinda Gooderham, Jean-Frederic Colombel, Tadashi Terui, Ana P Accioly, Gaia Gallo, Danting Zhu, Andrew Blauvelt
Issues - Giugno 2022
Christopher E M Griffiths, Melinda Gooderham, Jean-Frederic Colombel, Tadashi Terui, Ana P Accioly, Gaia Gallo, Danting Zhu, Andrew Blauvelt
Kristian Reich, Lars Erik Kristensen, Saxon D Smith, Phoebe Rich, Christophe Sapin, Soyi Liu Leage, Robert McKenzie, Christopher Schuster, Elisabeth Riedl, Melinda Gooderham
Efficacy and safety of ixekizumab versus adalimumab in biologic-naïve patients with active psoriatic arthritis and moderate-to-severe psoriasis: 52-week results from the randomized SPIRIT-H2H trial
Dermatol Pract Concept. 2022 Apr 1;12(2):e2022104Vivaswath S Ayyar, Jong Bong Lee, Weirong Wang, Meghan Pryor, Yanli Zhuang, Thomas Wilde, An Vermeulen
Minimal physiologically-based pharmacokinetic (mPBPK) metamodeling of target engagement in skin informs anti-IL17A drug development in psoriasis
Front Pharmacol. 2022 Apr 25;13:862291Craig Leonardi, Baojin Zhu, William N Malatestinic, William J Eastman, Jiaying Guo, Mwangi J Murage, Casey Kar-Chan Choong, Russel Burge, Andrew Blauvelt
Real-world biologic adherence, persistence, and monotherapy comparisons in US patients with psoriasis: Results from IBM MarketScan® databases
Adv Ther. 2022 May 16. Online ahead of printEmilie Sbidian, Anna Chaimani, Ignacio Garcia-Doval, Liz Doney, Corinna Dressler, Camille Hua, Carolyn Hughes, Luigi Naldi, Sivem Afach, Laurence Le Cleach
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
Cochrane Database Syst Rev. 2022 May 23;5(5):CD011535N Bernardini, N Skroza, E Tolino, A Marchesiello, A Mambrin, V Balduzzi, S Michelini, P Maddalena, S Volpe, I Proietti, C Potenza
HIV positive patient treated with ixekizumab
Clin Ter. 2022 May 25;173(3):195-197Andrew Blauvelt, Nianwen Shi, Mwangi J Murage, Scott A Kern, Najwa Somani, Russel Burge, Terri L Ridenour, Carolyn R Lew, Nicole M Zimmerman, Baojin Zhu
Healthcare resource utilization and costs among patients with psoriasis treated with ixekizumab or adalimumab over two years of follow-up in real-world settings
J Med Econ. 2022 May 26;1-44Delia Colombo, Luca Bianchi, Gabriella Fabbrocini, Salvatore Corrao, Annamaria Offidani, Luca Stingeni, Antonio Costanzo, Giovanni Pellacani, Ketty Peris, Federico Bardazzi, Giuseppe Argenziano, Silvana Ruffolo, Paolo Dapavo, Carlo Carrera, Maria Concetta Fargnoli, Aurora Parodi, Marco Romanelli, Piergiorgio Malagoli, Alessandro Zullo, Fabio Ferri, Martina Fiocchi, Emanuela Zagni
The CANOVA study real-world evidence of biologic treatments in moderate-severe psoriasis in italy: A gender perspective
Womens Health Rep (New Rochelle). 2022 May 2;3(1):450-457JJ Wu, A Kavanaugh, MG Lebwohl, R Gniadecki, JF Merola
Psoriasis and metabolic syndrome: implications for the management and treatment of psoriasis
J Eur Acad Dermatol Venereol. 2022 Jun;36(6):797-806M Gooderham, A Pinter, LK Ferris, RB Warren, T Zhan, J Zeng, AM Soliman, C Kaufmann, B Kaplan, H Photowala, B Strober
Long-term, durable, absolute Psoriasis Area and Severity Index and health-related quality of life improvements with risankizumab treatment: a post hoc integrated analysis of patients with moderate-to-severe plaque psoriasis
J Eur Acad Dermatol Venereol. 2022 Jun;36(6):855-865A Bregnhøj, KKH Thuesen, T Emmanuel, T Litman, CL Grek, GS Ghatnekar, C Johansen, L Iversen
HSP90 inhibitor RGRN-305 for oral treatment of plaque-type psoriasis: efficacy, safety and biomarker results in an open-label proof-of-concept study
Br J Dermatol. 2022;186: 861-874Hideaki Miyachi, Takaaki Konishi, Ryosuke Kumazawa, Hiroki Matsui, Sayuri Shimizu, Kiyohide Fushimi, Hiroyuki Matsue, Hideo Yasunaga
Treatments and outcomes of generalized pustular psoriasis: A cohort of 1516 patients in a nationwide inpatient database in Japan
JAAD 2022;86(6):1266-1274Inger Marie Skoie, Kjetil Bårdsen, Mari M Nilsen, Live E. Eidem, Tore Grimstad, Ingvild Dalen, Roald Omdal
Fatigue and expression of heat-shock protein genes in plaque psoriasis
CED 2022; 47(6):1068-1077Cæcilie Bachdal Johansen, Alexander Egeberg, Espen Jimenez-Solem, Lone Skov, Simon Francis Thomsen
Association of maternal psoriasis and small for gestational age or preterm birth: a nationwide matched cohort study in 69.080 singleton infants
CED 2022;47(6):1115-1123Wafaa A. Shehata, Mostafa A. Hammam, Rasha S. Enany, Sally M. El-Hefnawy, Shimaa Abdelsattar
Uncoupling protein 2 and dynamin-related protein 1 mRNA expressions as genetic markers for plaque psoriasis
IJD 2022; 61(6):710-717Bruno Halioua, Clara Chelli, Laurent Misery, Jonathan Taieb, Charles Taieb
Sleep disorders and psoriasis: An update
Acta Derm Venereol. 2022 Apr 27;102:adv00699Michael S. Garshick, Kamelia Drenkova, Tessa J. Barrett, Florencia Schlamp, Edward A. Fisher, Stuart Katz, Sanja Jelic, Andrea L. Neimann, Jose U. Scher, James Krueger, Jeffrey S. Berger
A randomized open-label clinical trial of lipid-lowering therapy in psoriasis to reduce vascular endothelial inflammation
J Invest Dermatol. 2022 Jun;142(6):1749-1752Hsien-Yi Chiu, Yi-Teng Hung, Shi-Wei Huang, Yu-Huei Huang